GlassScriptPhysician profile
Aslam M Khan
NPI 1982631750
$1,137.00
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $224 · 2021: $258 · 2022: $61.28 · 2023: $131 · 2024: $125 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $338.27 | 2019-2025 | Triclip, Gallant, Tacticath Ablation Catheter, Sensor Enabled |
| Janssen Pharmaceuticals, INC | $166.63 | 2020-2023 | Xarelto |
| Philips North America LLC | $150.20 | 2020-2024 | (5091) Amb Mon & Diag Und |
| Novartis Pharmaceuticals Corporation | $64.85 | 2021 | |
| Boston Scientific Corporation | $62.17 | 2022-2025 | Watchman Access System |
| Merck Sharp & Dohme LLC | $57.20 | 2022-2023 | Verquvo |
| Irhythm Technologies, INC. | $53.75 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.46 | 2021-2023 | Lifevest |
| Impulse Dynamics (USA) INC. | $35.74 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.68 | 2020 | |
| Cardiva Medical, INC. | $28.59 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $23.81 | 2024 | Onpattro |
| Vital Connect, INC | $23.16 | 2024 | Vitalpatch Rtm |
| Cmp Pharma, INC. | $20.29 | 2021 | |
| Medtronic Vascular, INC. | $17.51 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aslam Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.